Evidence map›Paper›PMID 27506496›Full record

ArticleScientific reports2016

A Functional Polymorphism (rs937283) in the MDM2 Promoter Region is Associated with Poor Prognosis of Retinoblastoma in Chinese Han Population.

Yongfa Jiao, Zhongming Jiang, Yuxia Wu, Xiaochong Chen, Xing Xiao, Haiying Yu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. TP53 mutations and MDM2 polymorphisms in breast and ovarian cancers: amelioration by drugs and natural compounds.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  6. Genetic Variations inCancers · 2025
    Article
  7. Review
  8. Article
  9. Murine Double Minute 2 Gene (Saudi journal of biological sciences · 2021
    Article
  10. Associations ofJournal of clinical medicine · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. The mouse double minute 2 309T>G polymorphism and retinoblastoma risk: A meta-analysis.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yongfa JiaoDepartment of Ophthalmology, Yishui Central Hospital, Linyi, Shandong, China.
Zhongming JiangDepartment of Ophthalmology, Yishui Central Hospital, Linyi, Shandong, China.
Yuxia WuYishui Center for Disease Control and Prevention, Linyi, Shandong, China.
Xiaochong ChenDepartment of Ophthalmology, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
Xing XiaoDepartment of Orthopedics, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
Haiying YuDepartment of Radiology, Shandong Cancer Hospital and Institute, Affiliated to Shandong Academy of Medical Science, Jinan, Shandong, China.
Shandong Provincial QianFoShan Hospital · CNShandong Center for Disease Control and Prevention · CNShandong Tumor Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effect of single nucleotide polymorphisms (SNPs) at MDM2 has been investigated in several cancer types. Three MDM2 SNPs(rs937283, rs2270744 and rs769412) have previously been suggested to be positively correlated with cancer. In this study, we aimed to explore the association of rs937283, rs2270744 and rs769412 polymorphisms with retinoblastoma (RB) risk, clinicopathological characteristics, and prognosis. Compared with wild-type genotype AA at rs937283, individuals carrying AG and GG genotype had a significantly increased risk for developing RB (OR = 1.86, 95% CI 1.13-3.08; OR = 2.48, 95% CI 1.10-5.62, respectively). RB patients with allele G at rs937283 were more susceptible to invasion and high tumor aggression (OR = 2.42, 95% CI 1.43-4.11; OR = 2.15, 95% CI 1.27-3.64, respectively). Kaplan-Meier curves and log-rank results revealed that RB patients harboring genotype GG and G allele at rs937283 had worse survival (P < 0.02 and P < 0.01, respectively). In addition, the A to G substitution at rs937283 significantly enhanced the transcription activity of the MDM2 gene in vitro. In vivo, we found that MDM2 mRNA and protein were overexpressed in individuals who carried the G allele at rs937283. This study suggested that the MDM2 rs937283 polymorphism is a novel functional SNP both in vitro and in vivo as well as a biomarker for poor prognosis in RB.

Indexed as

Polymorphism, Single NucleotidePromoter Regions, GeneticAdultAllelesAsian PeopleBiomarkers, TumorCase-Control StudiesCell Line, TumorChild, PreschoolChinaFemaleGenotypeHeLa CellsHumansInfantLinkage DisequilibriumBiomarkers, TumorMDM2 protein, humanProto-Oncogene Proteins c-mdm2

Identifiers

PMID27506496
PMCPMC4979029
OpenAlexW2503353985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.